Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. - Archive ouverte HAL Access content directly
Journal Articles Journal of Experimental Medicine Year : 2010

Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.

(1, 2) , (1) , (3) , (4) , (5) , (1, 2, 6, 7)
1
2
3
4
5
6
7

Abstract

Activation-induced deaminase (AID) is the mutator enzyme that initiates somatic hypermutation and isotype switching of the antibody genes in B lymphocytes. Undesired byproducts of AID function are oncogenic mutations. AID expression levels seem to correlate with the extent of its physiological and pathological functions. In this study, we identify AID as a novel Hsp90 (heat shock protein 90 kD) client. We find that cytoplasmic AID is in a dynamic equilibrium regulated by Hsp90. Hsp90 stabilizes cytoplasmic AID, as specific Hsp90 inhibition leads to cytoplasmic polyubiquitination and proteasomal degradation of AID. Consequently, Hsp90 inhibition results in a proportional reduction in antibody gene diversification and off-target mutation. This evolutionarily conserved regulatory mechanism determines the functional steady-state levels of AID in normal B cells and B cell lymphoma lines. Thus, Hsp90 assists AID-mediated antibody diversification by stabilizing AID. Hsp90 inhibition provides the first pharmacological means to down-regulate AID expression and activity, which could be relevant for therapy of some lymphomas and leukemias.

Dates and versions

pasteur-00819549 , version 1 (01-05-2013)

Identifiers

Cite

Alexandre Orthwein, Anne-Marie Patenaude, El Bachir Affar, Alain Lamarre, Jason C Young, et al.. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90.. Journal of Experimental Medicine, 2010, 207 (12), pp.2751-65. ⟨10.1084/jem.20101321⟩. ⟨pasteur-00819549⟩

Collections

RIIP INRS-IAF
57 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More